Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
13,125.00
0.00
(0.00%)
At close: February 28 at 4:59:07 PM GMT-3
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
2,875,500
2,875,500
1,547,200
1,384,300
3,639,900
Investing Cash Flow
-799,200
-799,200
-4,101,000
1,576,600
-563,700
Financing Cash Flow
-683,500
-683,500
149,300
-1,747,300
-2,086,200
End Cash Position
2,375,000
2,375,000
1,049,900
3,419,300
2,261,400
Income Tax Paid Supplemental Data
355,100
355,100
740,700
262,500
247,900
Interest Paid Supplemental Data
245,400
245,400
252,200
262,500
280,800
Capital Expenditure
-359,800
-359,800
-311,400
-243,200
-294,900
Issuance of Debt
--
--
997,200
--
--
Repayment of Debt
-650,000
-650,000
-809,900
-1,002,200
-170,000
Repurchase of Capital Stock
--
--
--
-750,000
-1,800,000
Free Cash Flow
2,515,700
2,515,700
1,235,800
1,141,100
3,345,000
12/31/2021 - 3/17/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AMGN.MX Amgen Inc.
6,032.00
0.00%
AMGN.BA Amgen Inc.
12,500.00
+0.81%
PFEB.F Pfizer Inc.
7.75
-1.27%
MRK.BA Merck & Co., Inc.
22,375.00
+1.94%
PFE.BA Pfizer Inc.
7,990.00
-0.12%
GSK.L GSK plc
1,466.50
+0.38%
GSK GSK plc
37.59
+0.78%
AMGN Amgen Inc.
308.06
+0.73%
GILD Gilead Sciences, Inc.
114.31
+2.07%
BMY Bristol-Myers Squibb Company
59.62
+1.39%